Clinical Trial Update: Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab in solid tumors induced by prior radiation exposure has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors Induced By Prior Radiation Exposure

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Solid Tumors Induced by Prior Radiation Exposure | Phase 2 | Status: TERMINATED | Results posted: 2019-08-28